Delivery Order SPE2DB22D2206-SPE2DB24FKF06
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.12, is a delivery order from the Defense Logistics Agency (DLA), a defense agency, for the supply of a specific pharmaceutical product - BUTALB-ACETAMIN-CAFF 50-300-40 100S. The contract is for a firm fixed price and has an ultimate completion date of June 9, 2025. The award is not set aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,264.35 Firm Fixed Price delivery order is for the supply of BUTALB-ACETAMIN-CAF-COD 50-300 100S medication, with a performance period through June 2025. The contract is not set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,354.22, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,474.20 with a firm fixed price and an ultimate completion date of February 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567331087 - BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.65, covers the delivery of 4567009809 ! BUTALB-ACETAMIN-CAFF 50-325-40 100S medication. The award has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,549.13 firm fixed-price delivery order is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S, a pharmaceutical product. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,236.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a performance period extending through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, with an ID of SPE2DB20D1100|SPE2DB24FA0H2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order with a firm fixed price of $4,682.62 and an ultimate completion date of February 5, 2024. The contract covers the delivery of various pharmaceutical products, including Butalb-Acetamin-Caff 50-325-40 500S, to support military treatment facilities, veterans' healthcare programs, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.86 Firm Fixed Price Delivery Order is for the supply of various pharmaceutical products, including butalbital-acetaminophen-caffeine-codeine 50-300 100s. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...